United Therapeutics (NASDAQ: UTHR) CEO trades under 1,734,410-option 10b5-1 plan
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp (UTHR) reported that Chairperson & CEO Martine A. Rothblatt, through family trusts, exercised 9,500 stock options at an exercise price of $135.42 per share, receiving 9,500 shares of common stock, and on the same date sold 9,500 shares in multiple open-market transactions at prices around $522–$536 per share.
After the option exercise, a family trust held 103,910 stock options. Additional holdings reported include 40,513 shares held directly and 166 shares held indirectly by spouse. All option exercises and related sales were made under a Rule 10b5-1 trading plan adopted on November 7, 2025, which continues until the earlier of exercising 1,734,410 stock options expiring March 15, 2027, or December 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.72M approx. pre-tax spread)
Exercise and Sale
19 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($5.01M)
Approx. gross sale proceeds
$5.01M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.72M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F18 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 240 | $522.4866 | $125K |
| Sale | Common Stock F1, F4, F2 | 1,264 | $523.6459 | $662K |
| Sale | Common Stock F1, F5, F2 | 441 | $524.5108 | $231K |
| Sale | Common Stock F1, F6, F2 | 895 | $525.5962 | $470K |
| Sale | Common Stock F1, F7, F2 | 2,105 | $526.7632 | $1.11M |
| Sale | Common Stock F1, F8, F2 | 2,135 | $527.5763 | $1.13M |
| Sale | Common Stock F1, F9, F2 | 1,200 | $528.5872 | $634K |
| Sale | Common Stock F1, F10, F2 | 659 | $529.5583 | $349K |
| Sale | Common Stock F1, F11, F2 | 201 | $531.006 | $107K |
| Sale | Common Stock F1, F12, F2 | 80 | $531.6223 | $43K |
| Sale | Common Stock F1, F13, F2 | 200 | $532.63 | $107K |
| Sale | Common Stock F1, F14, F2 | 80 | $535.215 | $43K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F15 | -- | -- | -- |
| holding | Common Stock F16 | -- | -- | -- |
| holding | Common Stock F17 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 103,910 shares (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (18)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $529.24 to $530.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $530.27 to $531.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $531.49 to $531.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $532.53 to $532.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $535.20 to $535.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F16. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F17. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $522.04 to $522.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $523.08 to $524.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $524.10 to $525.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $525.12 to $526.115. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $526.14 to $527.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $527.14 to $528.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $528.17 to $528.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 9,500 stock options
Shares sold: 9,500 shares
Exercise price: $135.42 per share
+4 more
7 metrics
Options exercised
9,500 stock options
Exercised on August 19, 2026 at $135.42 per share
Shares sold
9,500 shares
Sold on August 19, 2026 in multiple trades around $522–$536 per share
Exercise price
$135.42 per share
Stock option exercise into UTHR common stock
Post-exercise options held by trust
103,910 stock options
Derivative holdings after the reported exercise
Direct common shares
40,513 shares
Common stock held directly by the reporting person
Spouse-held shares
166 shares
Common stock held indirectly by spouse
10b5-1 plan option capacity
1,734,410 stock options
Maximum options to be exercised under plan expiring March 15, 2027 or by December 31, 2026
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, family trusts, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This exercise of stock options and sale... was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and sale of the resulting shares of common stock"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
family trusts financial
"Shares held in family trusts as to which the Reporting Person's spouse"
investment power financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
FAQ
What insider transactions did UTHR report for Martine A. Rothblatt on August 19, 2026?
On August 19, 2026, family trusts associated with Martine A. Rothblatt exercised 9,500 stock options at $135.42 per share, acquiring 9,500 United Therapeutics common shares, and sold 9,500 shares in multiple open-market trades at prices around $522–$536 per share.
Were the August 19, 2026 UTHR trades by Martine Rothblatt under a Rule 10b5-1 plan?
Yes. The option exercise and related share sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted by Martine A. Rothblatt on November 7, 2025, according to the Form 4 footnotes.
How many United Therapeutics options remain in the family trust after these transactions?
After the August 19, 2026 option exercise, a family trust associated with Martine A. Rothblatt held 103,910 stock options in United Therapeutics, as reported in the Form 4 derivative holdings line.
What are the key terms of Martine Rothblatt’s UTHR 10b5-1 trading plan?
The Rule 10b5-1 plan provides for option exercises and sales until the earlier of: (a) exercise of 1,734,410 stock options, all expiring on March 15, 2027, or (b) December 31, 2026, according to the Form 4 footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
